What is Sampre Nutritions share price return in the past 10 years?

Sampre Nutritions Ltd share price has appreciated 22% annually (CAGR) over the past ten years.

Sampre Nutritions Ltd - Stock Valuation and Financial Performance

Name: Sampre Nutritions
Brand: Sampre Nutritions

BSE: 530617 | NSE: | Consumer Food | Small Cap

Place order

Sampre Nutritions Share Price

₹69.39 -0.16 -0.23%
as on 24-Apr'24 16:01

DeciZen - make an informed investing decision on Sampre Nutritions

Based on:

Data

M-Cap below 100cr DeciZen not available

Sampre Nutritions stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

61.8 Cr.

52-wk low:

46.6

52-wk high:

102

Is Sampre Nutritions Ltd an attractive stock to invest in?

1. Is Sampre Nutritions Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Sampre Nutritions Ltd is a below average quality company.

2. Is Sampre Nutritions Ltd undervalued or overvalued?

The key valuation ratios of Sampre Nutritions Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Sampre Nutritions Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Sampre Nutritions Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Sampre Nutritions:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
ROCE % ⓘ	5.6%	5%	9%	6.1%	4.5%	6.4%	6%	3.7%	4.9%	4.8%	-
Value Creation Index ⓘ	-0.6	-0.7	-0.4	-0.6	-0.7	-0.6	-0.6	-0.7	-0.7	-0.7	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	15.3	10.1	45.1	33.6	32.7	28.7	24.9	18.2	23.1	37.1	32
Sales YoY Gr.	-	-34.1%	346.9%	-25.5%	-2.8%	-12.2%	-13.4%	-26.6%	26.9%	60.4%	-
Adj EPS ⓘ	0.7	0.5	1.9	0.9	0.5	0.5	0.7	0.2	0.7	0.5	-0.9
YoY Gr.	-	-32.9%	293.6%	-49.2%	-46.8%	0%	42%	-77.5%	318.8%	-23.9%	-
BVPS (₹) ⓘ	17.5	17.8	19.6	20.4	20.9	21.5	22.2	22.4	23	27.4	32.4
Adj Net Profit ⓘ	0.3	0.2	0.9	0.5	0.2	0.2	0.3	0.1	0.3	0.4	-1
Cash Flow from Ops. ⓘ	0.1	-0.3	1.2	-1	1.5	5.7	2.6	-0.2	2.4	0.9	-
Debt/CF from Ops. ⓘ	39.3	-11.4	6.6	-12.6	9.4	3.5	7.8	-119.8	8.8	19.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	10.3%	2.6%	14.3%	60.4%
Adj EPS ⓘ	-3.5%	0.4%	-10.4%	-23.9%
BVPSⓘ	5.1%	5.6%	7.2%	19%
Share Price	22%	23.7%	62.6%	-27.3%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	TTM
Return on Equity % ⓘ	4.1	2.7	9.9	4.7	2.4	2.4	3.2	0.7	3	2.2	-3
Op. Profit Mgn % ⓘ	11.9	18.3	6.2	8.9	9.3	13.1	15.7	18.8	15.2	10.9	7.8
Net Profit Mgn % ⓘ	2.2	2.2	2	1.4	0.7	0.9	1.4	0.4	1.4	0.9	-2.5
Debt to Equity ⓘ	0.2	0.5	0.8	1.3	1.4	1.9	1.9	2	1.9	0.9	-
Working Cap Days ⓘ	99	205	71	119	128	160	192	277	241	168	99
Cash Conv. Cycle ⓘ	34	117	33	56	77	73	62	125	130	93	35

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 14.30%

Debt to equity has declined versus last 3 years average to 0.89

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at 1.12%

Latest Financials - Sampre Nutritions Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-0.9	-
TTM Sales (₹ Cr.)	32.1	-
BVPS (₹.) ⓘ	32.4	-
Reserves (₹ Cr.) ⓘ	20	-
P/BV ⓘ	2.12	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	46.55 / 101.98
All Time Low / High (₹)	1.05 / 296.35
Market Cap (₹ Cr.)	61.8
Equity (₹ Cr.)	9
Face Value (₹)	10
Industry PE ⓘ	66.7

Management X-Ray of Sampre Nutritions:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Sampre Nutritions

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

This is a premium feature, Please click here to check our solutions.

Key Ratios of Sampre Nutritions

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Sales	15.32	10.09	45.09	33.58	32.65	28.68	24.85	18.23	23.13	37.11
Operating Expenses ⓘ	13.50	8.38	42.34	30.61	29.61	24.94	20.95	14.80	19.63	33.05
Manufacturing Costs	7.73	5.43	9.75	7.27	7.12	3.82	9.53	8.26	10.12	13.56
Material Costs	3.76	1.39	30.20	21.37	19.96	18.43	8.25	3.69	6.60	15.21
Employee Cost	0.39	0.27	0.33	0.44	0.71	0.71	0.81	0.67	0.72	1.25
Other Costs ⓘ	1.62	1.28	2.06	1.53	1.81	1.99	2.37	2.19	2.19	3.03
Operating Profit ⓘ	1.82	1.71	2.75	2.98	3.04	3.74	3.90	3.43	3.50	4.05
Operating Profit Margin (%)	11.9%	16.9%	6.1%	8.9%	9.3%	13.0%	15.7%	18.8%	15.1%	10.9%
Other Income ⓘ	0.09	0.16	0.06	0.08	0.11	0.03	0.18	0.03	0.28	0.07
Interest ⓘ	0.29	0.49	0.65	1.11	1.18	2.13	2.13	1.54	1.77	1.89
Depreciation ⓘ	1.18	1.17	1.15	1.29	1.48	1.40	1.49	1.81	1.63	1.82
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	0.44	0.21	1.01	0.66	0.48	0.24	0.46	0.11	0.37	0.42
Tax ⓘ	0.10	0.08	0.15	0.21	0.24	0.01	0.12	0.03	0.06	0.07
Profit After Tax	0.34	0.13	0.86	0.45	0.24	0.23	0.34	0.08	0.31	0.35
PAT Margin (%)	2.2%	1.3%	1.9%	1.3%	0.7%	0.8%	1.4%	0.4%	1.3%	0.9%
Adjusted EPS (₹)	0.7	0.3	1.8	0.9	0.5	0.5	0.7	0.2	0.6	0.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Equity and Liabilities
Shareholders Fund	8.45	8.58	9.45	9.90	10.14	10.37	10.71	10.78	11.09	18.82
Share Capital ⓘ	4.82	4.82	4.82	4.82	4.82	4.82	4.82	4.82	4.82	6.87
Reserves ⓘ	3.63	3.76	4.63	5.08	5.32	5.55	5.89	5.96	6.27	11.95
Minority Interest	0	0	0	0	0	0	0	0	0	0
Debt	1.96	3.44	7.40	12.65	13.19	18.20	18.84	20.50	20.63	15.28
Long Term Debt	0.36	1.66	3.89	6.78	9.16	10.98	10.80	12.21	12.76	10.74
Short Term Debt	1.60	1.78	3.51	5.88	4.03	7.22	8.05	8.29	7.87	4.54
Trade Payables	0.54	1.19	3.91	2.16	1.59	6.18	4.77	4.84	3.81	3.84
Others Liabilities ⓘ	3.69	3.40	3.06	1.45	2.35	3.32	3.07	2.16	2.17	5.65
Total Liabilities ⓘ	14.64	16.62	23.82	26.15	27.27	38.07	37.39	38.29	37.70	43.59
Fixed Assets
Gross Block	20.98	21.69	22.17	23.48	28.76	32.53	37.22	33.57	39.52	39.61
Accumulated Depreciation	10.83	12	13.16	14.39	15.88	17.24	18.68	15.83	17.33	19.08
Net Fixed Assetsⓘ	10.15	9.69	9.01	9.08	12.88	15.29	18.54	17.75	22.18	20.52
CWIP ⓘ	0	0	3.86	5.58	2.39	8.88	5.42	5.30	0	4.16
Investmentsⓘ	0	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Inventories	0.03	1.40	2.49	3.59	4.93	5.93	7.04	7.29	7.09	7.04
Trade Receivables	3.36	3.69	6.05	4.84	4.53	4.99	3.58	6.22	5.97	7.47
Cash Equivalents	0.04	0.04	0.23	0.27	0.24	0.34	0.85	0.10	0.08	0.13
Others Assetsⓘ	1.06	1.79	2.16	2.77	2.30	2.62	1.96	1.61	2.36	4.25
Total Assets ⓘ	14.64	16.62	23.82	26.15	27.27	38.07	37.39	38.29	37.70	43.59

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Cash Flow From Operating Activity ⓘ	0.05	-0.34	1.19	-1.04	1.50	5.68	2.58	-0.18	2.41	0.88
PBT ⓘ	0.44	0.21	1.01	0.66	0.48	0.24	0.46	0.11	0.37	0.42
Adjustment ⓘ	1.76	1.66	1.78	2.38	1.89	2.64	2.39	2.55	3.30	3.59
Changes in Working Capital ⓘ	-1.92	-2.06	-1.43	-3.82	-0.64	3.04	-0.02	-2.63	-0.95	-2.88
Tax Paid ⓘ	-0.23	-0.16	-0.17	-0.27	-0.23	-0.24	-0.25	-0.21	-0.32	-0.26
Cash Flow From Investing Activity ⓘ	-2.69	-0.67	-4.32	-3.06	-2	-10.29	-1.26	-0.90	-0.76	-4.32
Capex	-2.69	-0.71	-4.34	-3.07	-2.10	-10.31	-1.28	-0.90	-0.77	-4.32
Net Investments	0	-0.01	0	0	0	0	0	0	0	0
Others ⓘ	0	0.05	0.02	0.02	0.10	0.02	0.02	0	0	0
Cash Flow From Financing Activityⓘ	2.55	1.01	3.32	4.14	0.46	4.71	-0.82	0.33	-1.66	3.48
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	9.72
Net Proceeds from Borrowing ⓘ	0.16	1.30	2.24	2.88	2.81	2.78	-0.72	0.82	0.55	-2.02
Interest Paid ⓘ	-0.29	-0.47	-0.64	-1.11	-0.50	-1.26	-0.92	-0.74	-1.67	-1.78
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	2.67	0.19	1.73	2.37	-1.85	3.19	0.82	0.25	-0.54	-2.44
Net Cash Flow ⓘ	-0.09	0	0.20	0.04	-0.04	0.11	0.50	-0.75	-0.01	0.04

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23
Ratios
ROE (%)	4.14	1.52	9.53	4.69	2.43	2.27	3.19	0.7	2.81	2.32
ROCE (%)	7.57	6.09	11.14	8.79	7.06	8.71	8.45	5.26	6.65	6.56
Asset Turnover Ratio	1.12	0.65	2.23	1.34	1.22	0.88	0.66	0.48	0.61	0.91
PAT to CFO Conversion(x)	0.15	-2.62	1.38	-2.31	6.25	24.7	7.59	-2.25	7.77	2.51
Working Capital Days
Receivable Days	65	128	39	59	52	61	63	98	96	66
Inventory Days	4	26	16	33	48	69	95	143	114	70
Payable Days	124	226	31	52	34	77	242	476	240	92

Sampre Nutritions Ltd Stock News

Sampre Nutritions Ltd FAQs

What is the share price of Sampre Nutritions?

Company share prices are keep on changing according to the market conditions. The closing price of Sampre Nutritions on 24-Apr-2024 16:01 is ₹69.39.

What is the market cap of Sampre Nutritions?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 24-Apr-2024 16:01 the market cap of Sampre Nutritions stood at ₹61.78.

What is the P/E ratio of Sampre Nutritions?

The latest P/E ratio of Sampre Nutritions as of 24-Apr-2024 16:01 is 0.00.

What is the P/B ratio of Sampre Nutritions?

The latest P/B ratio of Sampre Nutritions as of 24-Apr-2024 16:01 is 2.12.

What is the 52-week high and low of Sampre Nutritions?

The 52-week high of Sampre Nutritions is ₹102.0 and the 52-week low is ₹46.55.

What is the TTM revenue of Sampre Nutritions?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Sampre Nutritions is ₹32.05 ( Cr.) .

About Sampre Nutritions Ltd

Sampre Nutritions was incorporated on December 3, 1991 as a Public company. Lately it was converted into a public limited company in 16 May 1994. The company is engaged in the manufacture and sale of sugar-boiled candies and toffees.

The multi-locational facilities of the Group are equipped with APV Baker 4 bank Deposited Line, New generation imported Uni plast lines cut & wrap lines, Cooling equipment and Packing machines. Continuous investments in the latest technology for each of the product lines have ensured the highest global standards. Supporting quality and optimum productivity across the integrated network are world-class laboratories and a strong R&D. The R&D also provides a one-stop source for everything from development to delivery of products to exacting international standards.

The companyâ€™s registered office is located at Kiran Arcade, 3 Floor, 100 Sarojini Devi Road Secunderabad,Andhra Pradesh-500003 .

Clientele

PROCTER & GAMBLE INDIA LTD
WARNER LAMBERT INDIA LTD
CADBURY INDIA LIMITED
INDIAN AIRLINES LTD
RANBAXY LABORATORIES LTD
KNOLL PHARMACEUTICALS LTD (BOOTS)
CIPLA LIMITED
DABUR INDIA LIMITED
AMRUTANJAN LIMITED
AUROBINDO PHARMA LIMITED
ANCHOR HEALTH & BEAUTY CARE PVT LTD
Dr. MOREPEN LABORATORIES LTD
HIMALAYA DRUG COMPANY
BAIDYANATH AYURVED BHAVAN PVT LTD
ELDER PHARMACEUTICALS LTD
MICRONUTRIENT, CANADA
ITC LIMITED

Awards and Achievements

The quality initiatives have credited the Group with many coveted citations viz., Pinnacle Awards by P&G, USA for Outstanding Quality Assurance Standards for 2 consecutive years, and the Golden Peacock National Quality Award in 1998 for Outstanding Quality Efforts in Small Sector Manufacturing.

The Rajiv Gandhi National Quality Award given by the Govt. of India and an ISO 9002 certification was topped by Sampre becoming the first confectionery Company in South East Asia to receive HACCP certification - the highest quality certification from BVQI â€“Netherlands for the Food industry.